Cargando…
ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells
BACKGROUND: Breast cancer is the most common women malignancy worldwide, while estrogen receptor alpha positive type accounts for two third of all breast cancers. Although ER alpha positive breast cancer could be effectively controlled by endocrine therapy, more than half of the cases could develop...
Autores principales: | Yang, Huijie, Lv, Xulei, Li, Xin, Mao, Lanzhi, Niu, Zhiguo, Wang, Ting, Zhuang, Ting, Huang, Qingsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987952/ https://www.ncbi.nlm.nih.gov/pubmed/33777799 http://dx.doi.org/10.3389/fonc.2021.638751 |
Ejemplares similares
-
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
por: Liu, Yun, et al.
Publicado: (2021) -
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
por: Niu, Zhiguo, et al.
Publicado: (2022) -
The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression
por: Niu, Zhiguo, et al.
Publicado: (2020) -
TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression
por: Zhuang, Ting, et al.
Publicado: (2022) -
Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)